OFIX Q2 2021 Earnings — Orthofix Medical Inc. Revenue & Financial Results | Market Cap Arena

OFIXOrthofix Medical Inc.

$503M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$121M+66.0% YoY

Gross Profit

$94M77.4% margin

Operating Income

$4M3.5% margin

Net Income

$2M2.0% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+15.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$502M

Total Liabilities

$140M

Stockholders' Equity

$362M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$73M	+66.0%
Gross Profit	$94M	$50M	+88.0%
Operating Income	$4M	-$21M	+120.3%
Net Income	$2M	-$18M	+113.1%

Revenue Segments

Bone Growth Therapies

$50M53%

Spinal Implants

$30M32%

Biologics

$15M16%

Geographic Segments

Bone Growth Therapies

$50M100%